Mark A. P. Konrad
YOU?
Author Swipe
View article: A non-clinical comparative study of IL-23 antibodies in psoriasis
A non-clinical comparative study of IL-23 antibodies in psoriasis Open
Four antibodies that inhibit interleukin (IL)-23 are approved for the treatment of moderate-to-severe plaque psoriasis. Here, we present non-clinical data comparing ustekinumab, guselkumab, tildrakizumab and risankizumab with regard to the…